Acanthamoeba infection claims another victim after Florida resident succumbs to rare amoebic disease. Doctors initially suspected vascular inflammation but confirmed the diagnosis through skin biopsies revealing amoebas consuming tissue. Nasal rinsing with contaminated water likely introduced the pathogen, which thrived due to the patient’s nasal polyps and immunosuppressant therapy for asthma.

The case highlights critical gaps in treating multidrug-resistant infections. After failing standard antifungal and antibacterial treatments, Yale physicians secured emergency FDA approval to administer nitroxoline—an antibiotic previously used for related infections. While the drug temporarily stabilized the patient’s condition, his immune system’s overactive response had already caused irreversible tissue damage. Necrotic lesions covered 70% of his body by the time treatment began.

This tragedy underscores risks in common hygiene practices. Over 1,000 Acanthamoeba cases were reported globally last year, with mortality rates exceeding 30% in immunocompromised patients. The Florida outbreak—linked to post-hurricane water contamination—revealed how climate-driven algal blooms exacerbate infection risks. Clinicians now urge caution against nasal irrigation in areas with poor water quality monitoring.

Key takeaway: Environmental changes and medical interventions can converge to create lethal health crises. Patients with chronic conditions must balance treatment benefits against emerging infection threats in ecologically vulnerable regions.